Traitement du vasospasme aux soins intensifs. [Vasospasm treatment in intensive care]

Détails

ID Serval
serval:BIB_4DA4D36F4EC2
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Traitement du vasospasme aux soins intensifs. [Vasospasm treatment in intensive care]
Périodique
Revue Médicale de la Suisse Romande
Auteur⸱e⸱s
Bracco  D., Chiolero  R.
ISSN
0035-3655 (Print)
Statut éditorial
Publié
Date de publication
04/2000
Volume
120
Numéro
4
Pages
355-62
Notes
English Abstract
Journal Article
Review --- Old month value: Apr
Résumé
Vasopasm is a dreadful complication of SAH associated with an important mortality and morbidity. Therapy begins with adequate monitoring and lines, and prevention of secondary brain injuries. 3-H therapy (hypervolemia--hypertension--hemodilution--hyperdynamism) aims to increase perfusion in ischemia areas. 3-H therapy is associated with systemic complication precluding it's prophylactic use. Calcium antagonists, in particular nimodipine, improve outcome and parenteral route is better than oral administration. Tirilazad seems to improve outcome of severe grades. Numerous experiments are performed with drugs interfering with the biochemical cascade leading to vasospasm, but up to today no drug is used in current clinical practice. Intraaortic balloon is still considered as experimental and may have a role in patients presenting with concomitant cardiac failure. Invasive radiology must be considered in vasospasm not improving with standard therapies. Vasopasm is a dire complication after SAH. Support and specific therapies allow a 3-fold reduction in morbidity associated with vasospasm. Vasospasm is a vital emergency, and intervention has to be quick and aggressive.
Mots-clé
Calcium Channel Blockers/therapeutic use Drainage Forecasting Humans *Intensive Care Vasospasm, Intracranial/*therapy
Pubmed
Création de la notice
24/01/2008 16:52
Dernière modification de la notice
20/08/2019 14:02
Données d'usage